Perspective Therapeutics (CATX) Change in Interest Receivables (2024 - 2026)

Perspective Therapeutics has disclosed Change in Interest Receivables across 3 years of filings, most recently posting $392000.0 for Q1 2026.

• Change in Interest Receivables for Q1 2026 came in at $392000.0, up 429.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $460000.0 (down 51.78% YoY), and the FY2025 annual result was $142000.0, down 83.86% from the prior year.
• Change in Interest Receivables came in at $392000.0 for Q1 2026 at Perspective Therapeutics, up from -$163000.0 in the prior quarter.
• In the past five years, Change in Interest Receivables ranged from a high of $880000.0 in Q4 2024 to a low of -$163000.0 in Q4 2025.
• The 3-year median for Change in Interest Receivables is $143000.0 (2025), against an average of $235666.7.
• Across the five-year window, Change in Interest Receivables tumbled 118.52% in 2025 and soared 429.73% in 2026, its largest moves.
• Perspective Therapeutics' Change in Interest Receivables stood at $880000.0 in 2024, then sank by 118.52% to -$163000.0 in 2025, then jumped by 340.49% to $392000.0 in 2026.
• The last three Change in Interest Receivables figures came in at $392000.0 (Q1 2026), -$163000.0 (Q4 2025), and $19000.0 (Q3 2025), per Business Quant data.